Coldstream Capital Management Inc Amylyx Pharmaceuticals, Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMLX
# of Institutions
141Shares Held
53.7MCall Options Held
290KPut Options Held
205K-
Perceptive Advisors LLC New York, NY6.77MShares$33.2 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$29.1 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$27.9 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$20.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$13.1 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $287M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...